التفاصيل البيبلوغرافية
| العنوان: |
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. |
| المؤلفون: |
Byrne, Robert A, Fremes, Stephen, Capodanno, Davide, Czerny, Martin, Doenst, Torsten, Emberson, Jonathan R, Falk, Volkmar, Gaudino, Mario, McMurray, John J V, Mehran, Roxana, Milojevic, Milan, Uva, Miguel Sousa |
| المصدر: |
European Heart Journal; 11/1/2023, Vol. 44 Issue 41, p4310-4320, 11p |
| مصطلحات موضوعية: |
DRUG-eluting stents, CORONARY artery disease, CORONARY artery bypass, SURGICAL & topographical anatomy, MYOCARDIAL revascularization, PERCUTANEOUS coronary intervention, MYOCARDIAL infarction |
| الشركة/الكيان: |
EUROPEAN Society of Cardiology |
| مستخلص: |
In October 2021, the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) jointly agreed to establish a Task Force (TF) to review recommendations of the 2018 ESC/EACTS Guidelines on myocardial revascularization as they apply to patients with left main (LM) disease with low-to-intermediate SYNTAX score (0–32). This followed the withdrawal of support by the EACTS in 2019 for the recommendations about the management of LM disease of the previous guideline. The TF was asked to review all new relevant data since the 2018 guidelines including updated aggregated data from the four randomized trials comparing percutaneous coronary intervention (PCI) with drug-eluting stents vs. coronary artery bypass grafting (CABG) in patients with LM disease. This document represents a summary of the work of the TF; suggested updated recommendations for the choice of revascularization modality in patients undergoing myocardial revascularization for LM disease are included. In stable patients with an indication for revascularization for LM disease, with coronary anatomy suitable for both procedures and a low predicted surgical mortality, the TF concludes that both treatment options are clinically reasonable based on patient preference, available expertise, and local operator volumes. The suggested recommendations for revascularization with CABG are Class I, Level of Evidence A. The recommendations for PCI are Class IIa, Level of Evidence A. The TF recognized several important gaps in knowledge related to revascularization in patients with LM disease and recognizes that aggregated data from the four randomized trials were still only large enough to exclude large differences in mortality. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Heart Journal is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
